Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing DSSTox_CID_3342 listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

DSSTox_CID_3342
Canada

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

DSSTox_CID_3342

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 5 USDMF, 3 CEP/COS, 1 JDMF, 5 EU WC, 6 NDC API, 7 Listed Suppliers, $ API Reference Price

14 API Suppliers
5 USDMF
3 CEP/COS
1 JDMF
5 EU WC
6 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 52 FDA Orange Book, 1 Europe, 5 Canada, 2 South Africa, 3 Listed Dossiers

63 FDF Dossiers
52 FDA Orange Book
1 Europe
5 Canada
2 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG
TABLET;ORAL - 40MG
TABLET;ORAL - 80MG
TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 42 Direct Compression, 30 Disintegrants & Superdisintegrants, 26 Granulation, 25 Controlled & Modified Release, 20 Co-Processed Excipients, 17 Lubricants & Glidants, 17 Taste Masking, 16 Thickeners and Stabilizers, 15 Chewable & Orodispersible Aids, 10 Solubilizers, 7 Parenteral, 6 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Topical

86 Fillers, Diluents & Binders
42 Coating Systems & Additives
42 Direct Compression
30 Disintegrants & Superdisintegrants
26 Granulation
25 Controlled & Modified Release
20 Co-Processed Excipients
17 Lubricants & Glidants
17 Taste Masking
16 Thickeners and Stabilizers
15 Chewable & Orodispersible Aids
10 Solubilizers
7 Parenteral
6 Film Formers & Plasticizers
6 API Stability Enhancers
5 Empty Capsules
4 Vegetarian Capsules
4 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents
1 Surfactant & Foaming Agents
1 Topical

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 17 Finished Drug Prices

2 US Medicaid Prescriptions
17 Finished Drug Prices

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 6 Others

2 EDQM
1 USP
6 Others

$ API Ref.Price (USD/KG) : 805 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 3APOTEX INC

02 2MINT PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

5 All

01 5NADOLOL

filter Dosage Form Reset all filters

5 All

01 5TABLET

filter Brand Name Reset all filters

5 All

01 3APO-NADOLOL

02 2MINT-NADOLOL

FDF Dossiers
FDA Orange Book
Europe
Canada
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

APOTEX INC

BioProcess International

Not Confirmed

APOTEX INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging : 100

Approval Date :

Application Number : 782467

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

BioProcess International

Not Confirmed

APOTEX INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 160MG

Packaging : 100

Approval Date :

Application Number : 782475

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

BioProcess International

Not Confirmed

APOTEX INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging : 100

Approval Date :

Application Number : 782505

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MINT PHARMACEUTICALS INC

BioProcess International

Not Confirmed

MINT PHARMACEUTICALS INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MINT-NADOLOL

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2496380

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MINT PHARMACEUTICALS INC

BioProcess International

Not Confirmed

MINT PHARMACEUTICALS INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MINT-NADOLOL

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 2496399

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?